๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Herpes simplex virus-induced cardiomyopathy successfully treated with acyclovir

โœ Scribed by Petr Kuchynka; Tomas Palecek; Hana Hrbackova; Ivana Vitkova; Stanislav Simek; Eduard Nemecek; Viktor Aster; William E. Louch; Michael Aschermann; Ales Linhart

Publisher
Springer Vienna
Year
2010
Tongue
English
Weight
310 KB
Volume
122
Category
Article
ISSN
0043-5325

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Nucleotide sequence of thymidine kinase
Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: Evidence for reactivation of acyclovir-resistant herpes simplex virus
โœ Saijo, Masayuki; Suzutani, Tatsuo; Itoh, Kiminari; Hirano, Yoshiki; Murono, Koic ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 235 KB ๐Ÿ‘ 3 views

Recurrent acyclovir (ACV)-resistant (ACV-r) herpes simplex virus type 1 (HSV-1) infections occurred in a patient with Wiskott-Aldrich syndrome, an X-linked recessive immunodeficiency syndrome composed of three clinical characteristics of immunodeficiency, thrombocytopenia, and an eczematous dermatit

Potential for combined therapy with 348u
Potential for combined therapy with 348u87, a ribonucleotide reductase inhibitor, and acyclovir as treatment for acyclovir-resistant herpes simplex virus infection
โœ Dr. S. Safrin; T. Schacker; J. Delehanty; E. Hill; L. Corey ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 348 KB

inhibitors of the ribonucleotide reductase of herpes simplex viruses (HSV) potentiate the activity of acyclovir in vitro and in animal studies. In addition, the combination of the ribonucleotide reductase inhibitor 348U87 and acyclovir has synergistic therapeutic effects against infections in mice d